Losartan and ozagrel reverse retinal arteriolar constriction in non-obese diabetic mice
about
Hypoxia and the expression of HIF-1alpha and HIF-2alpha in the retina of streptozotocin-injected mice and ratsReduced ocular blood flow as an early indicator of diabetic retinopathy in a mouse model of diabetes.Oxygen delivery, consumption, and conversion to reactive oxygen species in experimental models of diabetic retinopathyIntravital video microscopy measurements of retinal blood flow in miceMeasurement of retinal blood flow rate in diabetic rats: disparity between techniques due to redistribution of flow.Update on animal models of diabetic retinopathy: from molecular approaches to mice and higher mammalsOzagrel reverses streptozotocin-induced constriction of arterioles in rat retinaAttenuation of diabetes-induced retinal vasoconstriction by a thromboxane receptor antagonist.Ocular dysfunction in a mouse model of chronic gut inflammation.Decreased retinal blood flow in experimental colitis; improvement by eye drop administration of losartanExpression of thromboxane synthase and the thromboxane-prostanoid receptor in the mouse and rat retina.Could donor multipotent mesenchymal stromal cells prevent or delay the onset of diabetic retinopathy?Increase in retinal hypoxia-inducible factor-2α, but not hypoxia, early in the progression of diabetes in the rat.Animal Models of Diabetic RetinopathyRetinal blood flow abnormalities following six months of hyperglycemia in the Ins2(Akita) mouse.Temporal development of retinal arteriolar endothelial dysfunction in porcine type 1 diabetesAttenuation of streptozotocin-induced microvascular changes in the mouse retina with the endothelin receptor A antagonist atrasentan.Inhibition of 20-HETE attenuates diabetes-induced decreases in retinal hemodynamics.Models of retinal diseases and their applicability in drug discovery.Effect of tempol on diabetes-induced decreases in retinal blood flow in the mouse.Intravitreal pro-inflammatory cytokines in non-obese diabetic mice: Modelling signs of diabetic retinopathy
P2860
Q33665353-051182CA-AFB4-4085-B2E5-D0C655803B02Q33709609-0E6D9AF1-D81D-431A-BB6D-9FFDD34550C7Q33737370-B14F5F20-26F2-4A36-912B-034CACE09FB4Q33828272-3623711A-6405-45C7-BC03-5AC7F45180F5Q34661428-8718582A-AC6E-4808-AE67-0D81C17BE891Q36051041-7EBBE5B5-6341-41E5-B793-00605CE71D45Q37012608-058E4BDE-D357-415F-8C7B-86AC02752716Q37096956-9067B268-8BA7-4BCF-9929-1F7CB1724D90Q37110193-3DC3EAAB-FD50-4581-8B3D-A7B971FEC5D0Q37227903-0ECE67D6-CD37-4764-9FBF-9C586ACAAA18Q37370517-409BE605-BC7C-4E58-BE99-F3BD124715E7Q38115020-1BA24524-841A-4C0E-BEA3-329C49A7925FQ38585336-D40B831E-A23C-40E1-BB74-8B5F3F421D6FQ41504603-83189A97-FA8D-4D72-8693-038909080C03Q42141781-56693B7F-5E08-46A8-BE6B-77171E15CCF1Q42382660-D918993F-7CB2-4DAD-B913-A285C7B87CB0Q42400411-859DCD93-D686-4C32-B305-30352444005FQ42824768-E086F625-D3C3-4E57-9172-B859F99EE0C1Q49574913-6D06FB70-1AB6-472A-9314-2287E1F353F2Q50539855-A51082A4-F9E8-4FB4-9C31-68ABB4F24D1DQ58723006-A487EFA6-891B-46D2-9600-28C9112410CD
P2860
Losartan and ozagrel reverse retinal arteriolar constriction in non-obese diabetic mice
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Losartan and ozagrel reverse retinal arteriolar constriction in non-obese diabetic mice
@en
type
label
Losartan and ozagrel reverse retinal arteriolar constriction in non-obese diabetic mice
@en
prefLabel
Losartan and ozagrel reverse retinal arteriolar constriction in non-obese diabetic mice
@en
P2860
P1433
P1476
Losartan and ozagrel reverse retinal arteriolar constriction in non-obese diabetic mice
@en
P2093
Norman R Harris
Seungjun Lee
P2860
P304
P356
10.1080/10739680701829802
P577
2008-07-01T00:00:00Z